Influence of information provided prior to switching from Humira to biosimilar adalimumab on UK patients’ satisfaction: a cross-sectional survey by patient organisations

• Peter C Taylor,
• Daniel Prieto-Alhambra,
• Sarah Berry,
• Ailsa Bosworth,
• Clare Jacklin,
• Kayoko Kaneko,
• Sally Dickinson,
• Helen McAteer

Affiliations

Peter C Taylor

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, UK

Daniel Prieto-Alhambra

Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK

Sarah Berry

Crohn’s & Colitis, Hatfield, UK

Ailsa Bosworth

National Rheumatoid Arthritis Society (NRAS), Maidenhead, UK

Clare Jacklin

National Rheumatoid Arthritis Society (NRAS), Maidenhead, UK

Kayoko Kaneko

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, UK

Sally Dickinson

National Axial Spondyloarthritis Society, London, UK

Helen McAteer

Psoriasis Association, Northampton, UK